UroGen Pharma Ltd. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Ra'anana, Israel
SEC filing record 1 source field available
Fiscal year end
31 December
UroGen Pharma Ltd. has filed 577 SEC EDGAR filings since 04 Mar 2016

SEC filing history

Showing 151-175 of 577 matching filings.

Per page
25
Current page
7
424B5 File 333-268398

424B5

Filing date
18 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-268398

424B5

Filing date
17 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jun 2024
Reporting date
10 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38079

144 filing

Filing date
11 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89992

SC 13G/A filing

Filing date
08 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-38079

FORM 10-K/A

Filing date
29 Apr 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
4

FORM 4

Filing date
20 Mar 2024
Reporting date
18 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38079

144 filing

Filing date
18 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-89992

SC 13D/A

Filing date
22 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89992

SC 13G/A

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89992

SC 13G/A filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89992

SC 13G/A

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89992

UROGEN PHARMA LTD.

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89992

SC 13G/A filing

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
12 Feb 2024
Reporting date
31 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
12 Feb 2024
Reporting date
25 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .